赣能股份：10月24日召开董事会会议

Group 1 - The core point of the article is that Ganneng Co., Ltd. held a temporary board meeting on October 24, 2025, to review the performance assessment results of its management team for the year 2024 [1] - For the first half of 2025, Ganneng's revenue composition was 99.75% from electricity and 0.25% from other sources [1] - As of the report date, Ganneng's market capitalization was 10.5 billion yuan [1] Group 2 - The article also highlights that the Chinese innovative drug sector has generated $80 billion in overseas licensing deals this year, indicating a hot secondary market in biomedicine [1] - There is a contrast noted between the thriving secondary market and the cooling fundraising environment in the primary market for biomedicine [1]